
---
title: '昭衍新药：一季度净利润同比增长34.27%'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=5813'
author: 证券时报网
comments: false
date: Thu, 28 Apr 2022 23:07:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=5813'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS603127" style="color: #2f67d1;text-decoration: none;" code="603127" target="_blank">昭衍新药</a>(603127)4月28日晚间披露一季报，一季度实现营业收入2.71亿元，同比增长34.82%；净利润1.25亿元，同比增长34.27%；基本每股收益0.33元。</p>

                  
</div>
            